vs
Side-by-side financial comparison of WARRIOR MET COAL, INC. (HCC) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $458.6M, roughly 1.1× WARRIOR MET COAL, INC.). WARRIOR MET COAL, INC. runs the higher net margin — 15.8% vs 6.8%, a 9.0% gap on every dollar of revenue. On growth, WARRIOR MET COAL, INC. posted the faster year-over-year revenue change (52.1% vs -1.7%). Over the past eight quarters, WARRIOR MET COAL, INC.'s revenue compounded faster (7.5% CAGR vs -0.1%).
Warrior Met Coal, Inc. (ticker HCC) is a U.S.-headquartered mining enterprise that produces and distributes high-grade metallurgical coal, a key raw material for steel production. It serves steel manufacturers and industrial clients across core markets including North America, Europe, and Asia.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
HCC vs MD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $458.6M | $493.8M |
| Net Profit | $72.3M | $33.7M |
| Gross Margin | 36.7% | — |
| Operating Margin | 17.3% | 9.9% |
| Net Margin | 15.8% | 6.8% |
| Revenue YoY | 52.1% | -1.7% |
| Net Profit YoY | — | 10.5% |
| EPS (diluted) | $1.37 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $458.6M | — | ||
| Q4 25 | $384.0M | $493.8M | ||
| Q3 25 | $328.6M | $492.9M | ||
| Q2 25 | $297.5M | $468.8M | ||
| Q1 25 | $299.9M | $458.4M | ||
| Q4 24 | $297.5M | $502.4M | ||
| Q3 24 | $327.7M | $511.2M | ||
| Q2 24 | $396.5M | $504.3M |
| Q1 26 | $72.3M | — | ||
| Q4 25 | $23.0M | $33.7M | ||
| Q3 25 | $36.6M | $71.7M | ||
| Q2 25 | $5.6M | $39.3M | ||
| Q1 25 | $-8.2M | $20.7M | ||
| Q4 24 | $1.1M | $30.5M | ||
| Q3 24 | $41.8M | $19.4M | ||
| Q2 24 | $70.7M | $-153.0M |
| Q1 26 | 36.7% | — | ||
| Q4 25 | 29.5% | — | ||
| Q3 25 | 27.1% | — | ||
| Q2 25 | 23.9% | — | ||
| Q1 25 | 18.1% | — | ||
| Q4 24 | 23.1% | — | ||
| Q3 24 | 29.3% | — | ||
| Q2 24 | 34.1% | — |
| Q1 26 | 17.3% | — | ||
| Q4 25 | 9.0% | 9.9% | ||
| Q3 25 | 6.3% | 13.8% | ||
| Q2 25 | 2.6% | 12.8% | ||
| Q1 25 | -5.8% | 7.0% | ||
| Q4 24 | -1.4% | 7.8% | ||
| Q3 24 | 11.9% | 6.6% | ||
| Q2 24 | 17.9% | -31.3% |
| Q1 26 | 15.8% | — | ||
| Q4 25 | 6.0% | 6.8% | ||
| Q3 25 | 11.1% | 14.5% | ||
| Q2 25 | 1.9% | 8.4% | ||
| Q1 25 | -2.7% | 4.5% | ||
| Q4 24 | 0.4% | 6.1% | ||
| Q3 24 | 12.7% | 3.8% | ||
| Q2 24 | 17.8% | -30.3% |
| Q1 26 | $1.37 | — | ||
| Q4 25 | $0.43 | $0.40 | ||
| Q3 25 | $0.70 | $0.84 | ||
| Q2 25 | $0.11 | $0.46 | ||
| Q1 25 | $-0.16 | $0.24 | ||
| Q4 24 | $0.02 | $0.37 | ||
| Q3 24 | $0.80 | $0.23 | ||
| Q2 24 | $1.35 | $-1.84 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $233.2M | $375.2M |
| Total DebtLower is stronger | $154.4M | $570.5M |
| Stockholders' EquityBook value | — | $865.9M |
| Total Assets | $2.8B | $2.2B |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $233.2M | — | ||
| Q4 25 | $300.0M | $375.2M | ||
| Q3 25 | $336.3M | $340.1M | ||
| Q2 25 | $383.3M | $224.7M | ||
| Q1 25 | $454.9M | $99.0M | ||
| Q4 24 | $491.5M | $229.9M | ||
| Q3 24 | $583.2M | $103.8M | ||
| Q2 24 | $709.0M | $19.4M |
| Q1 26 | $154.4M | — | ||
| Q4 25 | $154.3M | $570.5M | ||
| Q3 25 | $154.1M | $577.2M | ||
| Q2 25 | $153.9M | $583.9M | ||
| Q1 25 | $153.8M | $590.5M | ||
| Q4 24 | $153.6M | $597.1M | ||
| Q3 24 | $153.5M | — | ||
| Q2 24 | $153.3M | — |
| Q1 26 | — | — | ||
| Q4 25 | $2.1B | $865.9M | ||
| Q3 25 | $2.1B | $890.7M | ||
| Q2 25 | $2.1B | $833.8M | ||
| Q1 25 | $2.1B | $789.2M | ||
| Q4 24 | $2.1B | $764.9M | ||
| Q3 24 | $2.1B | $732.5M | ||
| Q2 24 | $2.0B | $706.5M |
| Q1 26 | $2.8B | — | ||
| Q4 25 | $2.8B | $2.2B | ||
| Q3 25 | $2.7B | $2.2B | ||
| Q2 25 | $2.6B | $2.1B | ||
| Q1 25 | $2.6B | $2.0B | ||
| Q4 24 | $2.6B | $2.2B | ||
| Q3 24 | $2.6B | $2.1B | ||
| Q2 24 | $2.6B | $2.0B |
| Q1 26 | — | — | ||
| Q4 25 | 0.07× | 0.66× | ||
| Q3 25 | 0.07× | 0.65× | ||
| Q2 25 | 0.07× | 0.70× | ||
| Q1 25 | 0.07× | 0.75× | ||
| Q4 24 | 0.07× | 0.78× | ||
| Q3 24 | 0.07× | — | ||
| Q2 24 | 0.07× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $114.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $76.1M | $114.1M | ||
| Q3 25 | $104.7M | $137.3M | ||
| Q2 25 | $37.5M | $137.2M | ||
| Q1 25 | $10.9M | $-117.5M | ||
| Q4 24 | $54.2M | $133.0M | ||
| Q3 24 | $62.2M | $91.8M | ||
| Q2 24 | $147.0M | $107.0M |
| Q1 26 | — | — | ||
| Q4 25 | 3.31× | 3.39× | ||
| Q3 25 | 2.86× | 1.91× | ||
| Q2 25 | 6.70× | 3.49× | ||
| Q1 25 | — | -5.66× | ||
| Q4 24 | 47.68× | 4.36× | ||
| Q3 24 | 1.49× | 4.72× | ||
| Q2 24 | 2.08× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HCC
| Sales | $448.5M | 98% |
| Other revenues | $10.1M | 2% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
